Skip to content
Terns Pharmaceuticals Inc icon

Terns Pharmaceuticals Inc

TERNStocksBiotechnologyUnited StatesNasdaqUSD

Price

$53.00

Today

+0.1%

YTD

+31.4%

About

Terns Pharmaceuticals Inc is an innovative biotech firm dedicated to pioneering and marketing therapeutic solutions on an international scale. Its work is primarily focused on the fields of liver disease and cancer. Operating in the biotechnology industry, Terns Pharmaceuticals Inc aims to mitigate the pathophysiological impacts of liver diseases like Non-alcoholic Steatohepatitis (NASH) and cancer. Although it operates independently, TERN boasts strategic partnerships with renowned pharmaceutical organisations. Its services encompass all stages of drug development, from discovery to clinical development, to bring novel, life-changing drugs to market. Monitor TERN's share price by adding it to your eToro watchlist.

Price chart
Closing price history for TERN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-51.28
P/S (TTM)0.00
P/B (TTM)5.91
Market cap$6.12B
Cap tierMid-cap
Industry avg P/E-6.22

Profitability

Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-14.23%
ROA-13.85%

Earnings & Revenue

Revenue (TTM)$0.00
Revenue growth (1Y)-100.0%
EPS (TTM)-$1.03
Free cash flow$-82.18M
Total debt$919,000.00

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.98
Employees59
Next earnings7 May '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.